ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 247 filers reported holding ICU MED INC in Q4 2022. The put-call ratio across all filers is 4.98 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $678,357 | -35.5% | 5,700 | -3.4% | 0.02% | -30.4% |
| Q2 2023 | $1,051,321 | +20.2% | 5,900 | +11.3% | 0.02% | +4.5% |
| Q1 2023 | $874,288 | +102757.4% | 5,300 | -1.9% | 0.02% | -4.3% |
| Q4 2022 | $850 | -99.9% | 5,400 | +1.9% | 0.02% | 0.0% |
| Q3 2022 | $798,000 | -10.9% | 5,300 | 0.0% | 0.02% | -4.2% |
| Q2 2022 | $896,000 | -25.0% | 5,300 | +1.9% | 0.02% | -14.3% |
| Q1 2022 | $1,194,000 | -1.3% | 5,200 | +2.0% | 0.03% | +3.7% |
| Q4 2021 | $1,210,000 | +1.7% | 5,100 | 0.0% | 0.03% | -6.9% |
| Q3 2021 | $1,190,000 | +13.3% | 5,100 | 0.0% | 0.03% | +16.0% |
| Q2 2021 | $1,050,000 | +0.2% | 5,100 | 0.0% | 0.02% | -7.4% |
| Q1 2021 | $1,048,000 | -0.3% | 5,100 | +4.1% | 0.03% | -10.0% |
| Q4 2020 | $1,051,000 | +17.3% | 4,900 | 0.0% | 0.03% | -26.8% |
| Q3 2020 | $896,000 | +1.2% | 4,900 | +2.1% | 0.04% | -22.6% |
| Q2 2020 | $885,000 | -6.6% | 4,800 | +2.1% | 0.05% | -23.2% |
| Q1 2020 | $948,000 | +7.8% | 4,700 | 0.0% | 0.07% | +56.8% |
| Q4 2019 | $879,000 | +19.8% | 4,700 | +2.2% | 0.04% | +12.8% |
| Q3 2019 | $734,000 | -31.4% | 4,600 | +7.0% | 0.04% | -27.8% |
| Q2 2019 | $1,070,000 | +1.6% | 4,300 | -2.3% | 0.05% | +1.9% |
| Q1 2019 | $1,053,000 | +4.3% | 4,400 | 0.0% | 0.05% | -7.0% |
| Q4 2018 | $1,010,000 | -20.6% | 4,400 | -2.2% | 0.06% | +5.6% |
| Q3 2018 | $1,272,000 | +5.6% | 4,500 | +9.8% | 0.05% | 0.0% |
| Q2 2018 | $1,204,000 | +19.2% | 4,100 | +2.5% | 0.05% | +17.4% |
| Q1 2018 | $1,010,000 | -28.1% | 4,000 | -38.5% | 0.05% | -28.1% |
| Q4 2017 | $1,404,000 | +23.8% | 6,500 | +6.6% | 0.06% | +20.8% |
| Q3 2017 | $1,134,000 | +7.8% | 6,100 | 0.0% | 0.05% | +1.9% |
| Q2 2017 | $1,052,000 | +14.8% | 6,100 | +1.7% | 0.05% | +13.0% |
| Q1 2017 | $916,000 | +5.4% | 6,000 | +1.7% | 0.05% | +2.2% |
| Q4 2016 | $869,000 | +7.4% | 5,900 | -7.8% | 0.04% | +4.7% |
| Q3 2016 | $809,000 | +12.0% | 6,400 | 0.0% | 0.04% | +13.2% |
| Q2 2016 | $722,000 | +8.4% | 6,400 | 0.0% | 0.04% | +8.6% |
| Q1 2016 | $666,000 | -7.8% | 6,400 | 0.0% | 0.04% | -5.4% |
| Q4 2015 | $722,000 | +4.6% | 6,400 | +1.6% | 0.04% | +2.8% |
| Q3 2015 | $690,000 | +16.4% | 6,300 | +1.6% | 0.04% | +28.6% |
| Q2 2015 | $593,000 | +6.1% | 6,200 | +3.3% | 0.03% | +3.7% |
| Q1 2015 | $559,000 | +6.7% | 6,000 | -6.2% | 0.03% | +12.5% |
| Q4 2014 | $524,000 | +31.7% | 6,400 | +3.2% | 0.02% | +26.3% |
| Q3 2014 | $398,000 | +3.9% | 6,200 | -1.6% | 0.02% | +5.6% |
| Q2 2014 | $383,000 | +3.2% | 6,300 | +1.6% | 0.02% | 0.0% |
| Q1 2014 | $371,000 | -4.6% | 6,200 | +1.6% | 0.02% | 0.0% |
| Q4 2013 | $389,000 | – | 6,100 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |